Wednesday December 13, 2017 03:07

Heathcare Press Release : 27 Nov 2017

Second Phase 3 Study Results for LMTX(R) Published in the Journal of Alzheimer#s Heathcare—27 Nov 17

TauRx Therapeutics Ltd today reported the full results from its second Phase 3 clinical study of LMTX(R), the first tau aggregation inhibitor in Alzheimer's disease, published online in the Journal of Alzheimer's